Skip to main content
. 2018 Apr 19;8:6247. doi: 10.1038/s41598-018-24717-0

Figure 3.

Figure 3

Intracellular localization of ATP7B in HLCs obtained from control and patient iPSCs. (a) Confocal immunofluorescence analysis of HLCs immunolabeled for ATP7B and Golgin 97 (upper panels) or KDEL containing proteins (lower panels) as markers of Golgi complex and ER, respectively. White arrows point to Golgi complex containing ATP7B-H1069Q in patient HLCs. Scale bars: 10 µm. (b) Immuno-electron microscopy images demonstrate distribution of ATP7B in control and patient cells. ATP7B was preferentially localized at the Golgi (white arrows) in control cells. Both cisternae of the ER (black arrows) and the Golgi membranes (white arrows) contained ATP7B in cells from patient. Scale bars: 300 nm. Graph represents % of ATP7B-associated gold particles (means ± SD) counted within ER and Golgi compartments in control and patient cells.